Your browser doesn't support javascript.
loading
Benefits of cardiac coherence combined with medical hypnosis on preoperative anxiety before cancer surgery: the COHEC II study trial protocol.
Amraoui, Jibba; Bordenave, Lauriane; Leclerc, Gilles; Salvignol, Geneviève; Jarlier, Marta; Fiess, Catherine; Philibert, Laurent; Fuzier, Régis; Touraine, Célia.
Afiliação
  • Amraoui J; Department of Anaesthesia, Montpellier Cancer Institute, University of Montpellier, Montpellier, France Jibba.Amraoui@icm.unicancer.fr.
  • Bordenave L; Gustave Roussy Institute, Villejuif, France.
  • Leclerc G; Department of Anaesthesia, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
  • Salvignol G; IUCT Oncopole, Toulouse, France.
  • Jarlier M; Biometrics Unit, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
  • Fiess C; Clinical Research and Innovation Department, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
  • Philibert L; Department of Pharmacy, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
  • Fuzier R; IUCT Oncopole, Toulouse, France.
  • Touraine C; Biometrics Unit, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
BMJ Open ; 13(12): e072215, 2023 12 12.
Article em En | MEDLINE | ID: mdl-38086587
ABSTRACT

INTRODUCTION:

Preoperative anxiety is a frequent problem that can lead to complications both during anaesthesia and in the postoperative period, especially in oncology. Studies have shown that it can be managed using non-pharmacological approaches, but few works have evaluated psychoeducational programmes. The aim of the COHErence Cardiaque (COHEC) II Study is to evaluate the combination of medical hypnosis (MH) and cardiac coherence (CC) training to manage preoperative anxiety in patients with cancer. METHODS AND

ANALYSIS:

COHEC II is an ongoing multicentre randomised clinical trial carried out in three French comprehensive cancer centres. In total, 296 patients who will undergo surgery for cancer will be recruited during 18 months and will be randomised in the control arm or the intervention arm. Patients in the intervention arm will follow a daily programme that combines MH and CC, starting 7 days before surgery. The control arm will receive the standard treatment to manage preoperative anxiety. The primary endpoint is the anxiety level on surgery day, measured using a Visual Analogue Scale. Secondary endpoints are patient adherence to the programme, satisfaction and postsurgery recovery quality. ETHICS AND DISSEMINATION The study protocol was approved by the French Ethics Committee (Comité de Protection des Personnes EST-II) on 24 November 2021 and will be carried out following the good practice guidelines and the Declaration of Helsinki. Results will be published in peer-reviewed journals and presented at conferences. TRIAL REGISTRATION NUMBER NCT05197972.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipnose / Neoplasias Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipnose / Neoplasias Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França